CSE bulletin 2025-1018

The common shares of Tempramed Technologies Ltd. have been approved for listing on the Canadian Securities Exchange.

Listing and disclosure documents will be available on the CSE website on the trading date.

Tempramed develops patent-protected technology designed to serve a broad range of medical and consumer products. Tempramed's primary business focus is revolutionizing injectors for temperature-sensitive medications by making them "smart" and temperature protected.

Issuer:  Tempramed Technologies

Security type:  common share

Symbol:  VIVI

Non-venture (NV) issuer:  no

Number of securities issued and outstanding:  73,435,348

Number of securities reserved for issuance:  31,500,505

CSE sector:  life sciences

Cusip No.:  88024B 10 2

ISIN:  CA 88024B 10 2 2

Board lot:  500

Trading currency:  Canadian dollar

Listing date:  Oct. 15, 2025

Other exchanges:  not applicable

Fiscal year-end:  Dec. 31

Transfer agent:  Endeavor Trust Corp.

The exchange is accepting market-maker applications for VIVI.